Roth Capital Downgrades eGain to Neutral, Lowers Price Target to $7

Benzinga Newsdesk www.benzinga.com Negative 89.4%

Neg 89.4% Neu 0% Pos 0%

Roth Capital analyst Richard Baldry downgrades eGain (NASDAQ:EGAN) from Buy to Neutral and lowers the price target from $21 to $7.